Skip to main content
. 2018 May 31;8:8512. doi: 10.1038/s41598-018-26869-5

Figure 6.

Figure 6

Effect of macro-devices’ porosity on the viability of encapsulated C2C12-EPO myoblasts within APA microcapsules. (a) Metabolic activity measured by the CCK8 assay. (b) Erythropoietin (EPO) secretion into the media. *p < 0.05 and ***p < 0.001 compared with device 1 at the same time point.